PROLIFERATION INHIBITION AND CD4 CD8 THYMOCYTE SUBSET SKEWING BY IN-VIVO EXPOSURE OF C57BL/6 MICE TO AH RECEPTOR-BINDING 3,3',4,4'-TETRACHLOROBIPHENYL/
C. Esser et al., PROLIFERATION INHIBITION AND CD4 CD8 THYMOCYTE SUBSET SKEWING BY IN-VIVO EXPOSURE OF C57BL/6 MICE TO AH RECEPTOR-BINDING 3,3',4,4'-TETRACHLOROBIPHENYL/, Experimental and clinical immunogenetics, 11(2-3), 1994, pp. 75-85
3,3',4, 4'-Tetrachlorobiphenyl (TCB) and other Ah receptor-binding xen
obiotics lead to thymus atrophy and immunosuppression, the former poss
ibly causing the latter. In order to better understand the TCB-induced
events in the murine thymus, we analyzed the effects of TCB on the pr
oliferation capacity and maturation kinetics of different thymocyte su
bsets in 2-week-old C57BL/6 mice (i.e. of the Ah(b-1) 'dioxin-sensitiv
e' genotype). Mice were injected with a single dose of TCB, and the de
velopment of thymocytes was followed up for 10 days using flow cytomet
ric surface marker analysis combined with measurement of DNA content b
y 7-amino-actinomycin D staining. Already 2 days after exposure to TCB
, fewer of the more immature thymocytes (CD4-CD8-, CD4-CD8+alpha beta
TCR-) were proliferating than in thymi from control animals. Eventuall
y this led to a severe decrease in thymus cellularity. Moreover, a shi
ft towards the CD4-CD8+ mature subpopulation was observed. The effects
were reversible, and proliferation and CD4/CD8 subset distribution re
turned to normal levels within the observation period. The results are
in good agreement with the data obtained previously in vitro with fet
al thymus organ cultures.